Karen Hunady | executive |
Conley Chee | executive |
David Roth | executive |
Jason Haas | executive |
Philip Nadeau | analyst |
Good morning, and welcome to Syros Pharmaceuticals First Quarter 2024 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors & Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded. At this time, I would like to turn the call over to Karen Hunady, Director of Investor Relations and Corporate Communications at Syros.
Thank you. This morning, we issued a press release announcing our first quarter 2024 financial results.